Literature DB >> 30796745

Longer genotypically-estimated leukocyte telomere length is associated with increased meningioma risk.

Ivo S Muskens1,2, Helen M Hansen3, Ivan V Smirnov3, Annette M Molinaro3, Melissa L Bondy4, Joellen M Schildkraut5, Margaret Wrensch3,6, Joseph L Wiemels2,3, Elizabeth B Claus7,8.   

Abstract

PURPOSE: Telomere length-associated SNPs have been associated with incidence and survival rates for malignant brain tumors such as glioma. Here, we study the influence of genetically determined lymphocyte telomere length (LTL) by comparing telomerase associated SNPs between the most common non-malignant brain tumor, i.e. meningioma, and healthy controls. METHODS/PATIENTS: One thousand fifty-three (1053) surgically treated meningioma patients and 4437 controls of Western European ancestry were included. Germline DNA was genotyped for 8 SNPs previously significantly associated with LTL. Genotypically-estimated LTL was then calculated by summing each SNP's genotypically-specified telomere length increase in base pairs (bp) for each person. Odds ratios for genotypically-estimated LTL in meningioma cases and controls were evaluated using logistic regression with the first two ancestral principal components and sex as covariates.
RESULTS: Three out of the eight evaluated LTL SNPs were significantly associated with increased meningioma risk (rs10936599: OR 1.14, 95% CI 1.01-1.28, rs2736100: OR 1.13, 95% CI 1.03-1.25, rs9420907: OR 1.22, 95% CI 1.07-1.39). Only rs9420907 remained significant after correction for multiple testing. Average genotypically-estimated LTL was significantly longer for those with meningioma compared to controls [mean cases: 560.2 bp (standard error (SE): 4.05 bp), mean controls: 541.5 bp (SE: 2.02 bp), logistic regression p value = 2.13 × 10-5].
CONCLUSION: Increased genotypically-estimated LTL was significantly associated with increased meningioma risk. A role for telomere length in the pathophysiology of meningioma is novel, and could lead to new insights on the etiology of meningioma.

Entities:  

Keywords:  Leukocyte telomere length; Mendelian randomization; Meningioma; Risk

Mesh:

Year:  2019        PMID: 30796745      PMCID: PMC6482066          DOI: 10.1007/s11060-019-03119-w

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  41 in total

1.  Principal components analysis corrects for stratification in genome-wide association studies.

Authors:  Alkes L Price; Nick J Patterson; Robert M Plenge; Michael E Weinblatt; Nancy A Shadick; David Reich
Journal:  Nat Genet       Date:  2006-07-23       Impact factor: 38.330

Review 2.  Telomerase and the aging process.

Authors:  Peter J Hornsby
Journal:  Exp Gerontol       Date:  2007-03-30       Impact factor: 4.032

3.  Leukocyte telomere length and cardiovascular disease in the cardiovascular health study.

Authors:  Annette L Fitzpatrick; Richard A Kronmal; Jeffrey P Gardner; Bruce M Psaty; Nancy S Jenny; Russell P Tracy; Jeremy Walston; Masyuki Kimura; Abraham Aviv
Journal:  Am J Epidemiol       Date:  2006-10-16       Impact factor: 4.897

Review 4.  The significance of human telomerase reverse transcriptase (hTERT) in cancer.

Authors:  K L Kirkpatrick; K Mokbel
Journal:  Eur J Surg Oncol       Date:  2001-12       Impact factor: 4.424

5.  Mammalian telomeres end in a large duplex loop.

Authors:  J D Griffith; L Comeau; S Rosenfield; R M Stansel; A Bianchi; H Moss; T de Lange
Journal:  Cell       Date:  1999-05-14       Impact factor: 41.582

6.  Implication of telomerase activity and alternations of telomere length in the histologic characteristics of intracranial meningiomas.

Authors:  H J Chen; C L Liang; K Lu; J W Lin; C L Cho
Journal:  Cancer       Date:  2000-11-15       Impact factor: 6.860

7.  Telomere shortening occurs in Asian Indian Type 2 diabetic patients.

Authors:  A Adaikalakoteswari; M Balasubramanyam; V Mohan
Journal:  Diabet Med       Date:  2005-09       Impact factor: 4.359

8.  Blood leucocyte telomere DNA content predicts vascular telomere DNA content in humans with and without vascular disease.

Authors:  W Richard W Wilson; Karl E Herbert; Yogita Mistry; Suzanne E Stevens; Hash R Patel; Richard A Hastings; Matthew M Thompson; Bryan Williams
Journal:  Eur Heart J       Date:  2008-09-01       Impact factor: 29.983

9.  Telomere length and mortality: a study of leukocytes in elderly Danish twins.

Authors:  Masayuki Kimura; Jacob V B Hjelmborg; Jeffrey P Gardner; Lise Bathum; Michael Brimacombe; Xiaobin Lu; Lene Christiansen; James W Vaupel; Abraham Aviv; Kaare Christensen
Journal:  Am J Epidemiol       Date:  2008-02-12       Impact factor: 4.897

10.  A DNA polymerase-{alpha}{middle dot}primase cofactor with homology to replication protein A-32 regulates DNA replication in mammalian cells.

Authors:  Darren E Casteel; Shunhui Zhuang; Ying Zeng; Fred W Perrino; Gerry R Boss; Mehran Goulian; Renate B Pilz
Journal:  J Biol Chem       Date:  2008-12-31       Impact factor: 5.157

View more
  7 in total

1.  Leukocyte telomere length is associated with aggressive prostate cancer in localized prostate cancer patients.

Authors:  Junfeng Xu; Wen-Shin Chang; Chia-Wen Tsai; Da-Tian Bau; Yifan Xu; John W Davis; Timothy C Thompson; Christopher J Logothetis; Jian Gu
Journal:  EBioMedicine       Date:  2020-01-22       Impact factor: 8.143

Review 2.  Risk factors for childhood and adult primary brain tumors.

Authors:  Quinn T Ostrom; Maral Adel Fahmideh; David J Cote; Ivo S Muskens; Jeremy M Schraw; Michael E Scheurer; Melissa L Bondy
Journal:  Neuro Oncol       Date:  2019-11-04       Impact factor: 12.300

Review 3.  Epidemiology of Brain and Other CNS Tumors.

Authors:  Quinn T Ostrom; Stephen S Francis; Jill S Barnholtz-Sloan
Journal:  Curr Neurol Neurosci Rep       Date:  2021-11-24       Impact factor: 6.030

Review 4.  Stress and telomere shortening: Insights from cellular mechanisms.

Authors:  Jue Lin; Elissa Epel
Journal:  Ageing Res Rev       Date:  2021-11-01       Impact factor: 10.895

5.  Long Leukocyte Telomere Length Is Associated with Increased Risks of Soft Tissue Sarcoma: A Mendelian Randomization Study.

Authors:  Yifan Xu; Junfeng Xu; Haidee Chancoco; Maosheng Huang; Keila E Torres; Jian Gu
Journal:  Cancers (Basel)       Date:  2020-03-05       Impact factor: 6.639

6.  Systematic review of Mendelian randomization studies on risk of cancer.

Authors:  Georgios Markozannes; Afroditi Kanellopoulou; Olympia Dimopoulou; Dimitrios Kosmidis; Xiaomeng Zhang; Lijuan Wang; Evropi Theodoratou; Dipender Gill; Stephen Burgess; Konstantinos K Tsilidis
Journal:  BMC Med       Date:  2022-02-02       Impact factor: 11.150

7.  Genetic predisposition to longer telomere length and risk of childhood, adolescent and adult-onset ependymoma.

Authors:  Chenan Zhang; Quinn T Ostrom; Eleanor C Semmes; Vijay Ramaswamy; Helen M Hansen; Libby Morimoto; Adam J de Smith; Melike Pekmezci; Zalman Vaksman; Hakon Hakonarson; Sharon J Diskin; Catherine Metayer; Michael D Taylor; Joseph L Wiemels; Melissa L Bondy; Kyle M Walsh
Journal:  Acta Neuropathol Commun       Date:  2020-10-28       Impact factor: 7.578

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.